GlassScriptPhysician profile
Thomas A Edwards
NPI 1871881201
$2,911.00
in general payments reported to CMS, 2019-2025
19 companies · $468 in 2025
The $468 reported for 2025 was more than what 79% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $208 · 2022: $52.20 · 2023: $1,830 · 2024: $352 · 2025: $468.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,375 · Travel and Lodging: $1,276.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,374.85 |
| Travel and Lodging | $1,275.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,489.41 | 2023 | Enseal |
| Abbvie INC. | $229.28 | 2019-2022 | |
| Astellas Pharma US INC | $193.07 | 2024-2025 | Veozah |
| Shield Therapeutics INC | $155.89 | 2023-2025 | Accrufer |
| Pfizer INC. | $141.71 | 2023-2025 | |
| Biogen, INC. | $118.00 | 2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $111.56 | 2023-2025 | Acessa Provu System, Novasure, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Ethicon US, LLC | $65.89 | 2022-2023 | Enseal |
| Sumitomo Pharma America, INC. | $65.53 | 2024-2025 | Myfembree |
| Organon LLC | $61.93 | 2023-2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $59.23 | 2023-2025 | Gardasil 9, Gardasil |
| Bayer Healthcare Pharmaceuticals INC. | $48.88 | 2023-2025 | |
| Channel Medsystems, INC. | $41.68 | 2024 | |
| Mayne Pharma Commercial LLC | $32.31 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $28.11 | 2023 | Exparel |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gynesonics, INC. | $20.44 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Agile Therapeutics, INC. | $18.45 | 2023 | Twirla |
| Convatec INC. | $15.96 | 2024 | |
| Exact Sciences Corporation | $13.67 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.